Company Overview
Snapshot
Founded in March 2009 by Ehud Almon and Dan Aravot, Deliverance operates with 11–50 employees. The company has raised $1M across one funding round, focusing on developing a line of Sealer and Filler TM bleeding management life-saving devices.
Business overview
Deliverance develops proprietary technologies for the immediate management and control of bleeding, hemorrhage, and shock resulting from blood vessel perforations. The company's core products include the Lap Braided S&F Catheter, designed for rapid sealing during minimally invasive surgeries, and the Open Surgery and Field S&F Catheter, which provides complete and rapid sealing with a dual blockade. Deliverance serves markets within the Health Tech & Life Sciences sector, specifically focusing on medical devices for surgeries and trauma care, targeting hospitals, surgeons, and military applications.
Log in to access full profile ›Company Intelligence Q&A
- What is Deliverance's primary focus?
- Deliverance focuses on developing core proprietary technologies to manage and control bleeding, hemorrhage, and shock caused by blood vessel perforations during surgeries and trauma.
- What are Deliverance's key product offerings?
- Deliverance offers the Lap Braided S&F Catheter for minimally invasive surgeries and the Open Surgery and Field S&F Catheter for open surgeries, both designed for rapid and complete sealing of blood vessel perforations.
- When was Deliverance founded and by whom?
- Deliverance was founded in March 2009 by Ehud Almon and Dan Aravot.
- What is the employee size of Deliverance?
- Deliverance operates with 11–50 employees.
- What is the total capital raised by Deliverance?
- Deliverance has raised a total of $1M in funding.